http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101647899-B1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-336 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-34 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-34 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-336 |
| filingDate | 2014-12-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2016-08-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2016-08-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-101647899-B1 |
| titleOfInvention | Pharmaceutical composition for preventing or treating for Helicobacter pylori infectious diseases |
| abstract | The present invention relates to a pharmaceutical composition, a quasi-drug composition for preventing or treating a bacterial infectious disease comprising PTL (parthenolide), DPI (diphenyleneiodonium chloride) or a pharmaceutically acceptable salt thereof as an active ingredient, A therapeutic kit and a method for treating a bacterial infection using the composition. Since PTL or DPI provided by the present invention exhibits antibacterial activity against H. pylori strains showing resistance to antibiotics, PTL or DPI can be widely used for the development of a therapeutic agent for H. pylori infection. |
| priorityDate | 2014-12-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 118.